Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

STRATEGIC RETREAT

THE WEEK India

|

March 30, 2025

VOLATILE TIMES ARE AN OPPORTUNITY FOR INVESTORS TO REVIEW THEIR FINANCIAL GOALS AND RISK TOLERANCE

- NACHIKET KELKAR

STRATEGIC RETREAT

In the past few years, lakhs of Indians have piled in to mutual funds, hoping to ride the bull run in the stock markets. But, over the past few months, the bears have been in charge, with the markets spiralling down amid massive selling by foreign institutional investors in the wake of global trade and tariff uncertainties and the worries over tepid corporate earnings and slow economic growth.

As of March 13, the BSE Sensex was down more than 14 per cent from its peak. The mid and small-cap stocks have seen a sharper fall-the BSE Midcap index tumbled over 21 per cent from its high and the BSE Smallcap index slumped 24 per cent. With one-year returns from SIPS (systematic investment plans) flashing red, more investors seem to be hitting the pause.

Total inflows into equity mutual fund schemes in February were down 26 per cent at around *29,303 crore, compared with January (around 39,687.78 crore). The inflows in January itself were 4 per cent lower than December.

Midcap and smallcap schemes, which had been a big draw among investors, have seen around 34 per cent decline in flows month-onmonth. Sectoral/thematic category, which saw numerous scheme launches over the past 18 months, too, have seen a sizeable decline in flows-down 37 per cent from ₹9,016.60 crore to ₹5,711.58 crore.

WEITERE GESCHICHTEN VON THE WEEK India

THE WEEK India

THE WEEK India

Fire, smoke and soaring worries

The PSLV C-62 fiasco is a stress test of ISRO's technical systems, organisational processes and market credibility

time to read

7 mins

January 25, 2026

THE WEEK India

THE WEEK India

The dinosaur and the dictator

Dictators have a few things in common with T. rex, the king of dinosaurs. Both dominate their sphere of influence through brute force.

time to read

2 mins

January 25, 2026

THE WEEK India

We are developing master plans for tourism destinations

Across the world, the tourism development is more about providing seamless connection and basic infra like transportation, lodging and boarding.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

A TIGHTROPE WALK

As small-caps are yet to find valuation comfort, 2026 would be a challenging year for them

time to read

4 mins

January 25, 2026

THE WEEK India

THE WEEK India

ON THIN ICE

With the intensification of great-power rivalries in the region, Greenland's strategic and resource potential has become salient

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Elgin, Ephesus and Erdogan

Lord Elgin was wrong. Not the eighth earl whom we know as a viceroy of India, but his more famous father, the seventh who had carted away the Parthenon Marbles from Athens during 1802-1812. Elgin feared the Ottoman Turks, who had occupied Greece, might vandalise them.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

Art at the heart

The sixth edition of the Kochi-Muziris Biennale reclaims its legacy

time to read

6 mins

January 25, 2026

THE WEEK India

THE WEEK India

BENIGN PROSTATIC HYPERPLASIA (BPH): Understanding Symptoms, Diagnosis & Modern Treatment Options

Benign Prostatic Hyperplasia (BPH) is a very common medical condition affecting aging men, particularly those above 50 years.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

ERA OF THE NEW NORMAL

The confrontations with China and Pakistan have added another dimension to the ever-evolving nature of the Indian military

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Affordable CAR-T Therapy Brings New Hope for Blood Cancer Patients in India

For thousands of Indians battling blood cancers, a once-unimaginable dream is fast becoming reality. Cutting-edge CART cell therapy a breakthrough treatment that uses a patient's own immune system to fight cancer is now available in India at a fraction of global costs, offering renewed hope to patients with advanced disease.

time to read

1 mins

January 25, 2026

Listen

Translate

Share

-
+

Change font size